Multifunctionality and Possible Medical Application of the BPC 157 PeptideLiterature and Patent Review The peptide problem: Hype is outrunning the evidence FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.'s Wishes The New York Times of the Federal Food, Drug, and Cosmetic Act (FDCA).* An FDA Reversal on Peptides Could Open the Market to Unsafe Drugs ProPublica Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law